Thomas Wilke
Investor @ Zelros
Munich, Germany
Thomas Wilke is an Entrepreneur, Investor, and Partner at 42CAP and an Investor at Nostos Genomics, Qdrant, Codesphere, ENLYZE, Lumiform, and more. Prior to that. he was the Founder and CTO of eCircle. He attended Karlsruhe Institute of Technology (KIT) and UMass Boston.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 38%
Last updated:
For AI agents: llms.txt
Industries Thomas Wilke invests in
Stages Thomas Wilke invests in
Countries Thomas Wilke invests in
Round sizes
Round size
- Seed
- $2.2M–$5.7M
- Pre-Seed
- $1.5M–$3.1M
Investment Focus
Industry
- Software 4 (31%)
- Artificial Intelligence 3 (23%)
- Biotechnology 2 (15%)
- Machine Learning 2 (15%)
- SaaS 1 (8%)
Stage
- Seed 6 (46%)
- Pre-Seed 3 (23%)
- Series A 1 (8%)
- Series B 1 (8%)
- Series C 1 (8%)
Country
- Germany 2 (15%)
- France 1 (8%)
- Sweden 1 (8%)
- Belgium 1 (8%)
- Switzerland 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ALP Bio
|
Alp Bio’s platform integrates tonsil organoid technology with advanced protein AI to identify and mitigate immunogenic risks in therapeutic antibodies, ensuring safer patient outcomes. | $2.2M / Pre-Seed / Apr 30, 2026 | |
Waypoint AI
|
Waypoint AI triages, deflects, routes, and does postmortems. before they become into crises. | $3.1M / Pre-Seed / Jun 26, 2025 | |
Flawless
|
Flawless has product, technology, operations, and profit and loss management experience from Fortune 500 companies and well-funded startups. | $2.2M / Seed / Sep 28, 2023 | |
Customs4trade (C4T)
|
The CAS digital platform manages more than one hundred thousand customs declarations every month for major brands such as Givaudan, Honda, Mizuno, Agristo, and many more, and delivers to customers the benefits of the increased digitisation of the customs sector as national governments across Europe move to upgrade customs systems over the course ofthe next couple of years. | $4.4M / Venture - Series Unknown / Apr 19, 2023 | |
Nostos Genomics
|
At Nostos Genomics, we partner with genetic testing labs to give more people with genetic diseases a clear and fast diagnosis. To achieve this, we developed a platform that leverages a unique combination of machine learning and synthetic biology. | $5.7M / Seed / Feb 03, 2022 | |
Superface
|
The future of APIs is true machine-to-machine communication. Autonomous APIs, decoupled components and self-driving clients are the foundation for voice interfaces and artificial intelligence. Superface uses super interface components that enable plug-and-play usage of data and services provided by companies using their API. | $3M / Seed / Jan 01, 2022 | |
|
Customs4trade (C4T)
|
The CAS digital platform manages more than one hundred thousand customs declarations every month for major brands such as Givaudan, Honda, Mizuno, Agristo, and many more, and delivers to customers the benefits of the increased digitisation of the customs sector as national governments across Europe move to upgrade customs systems over the course ofthe next couple of years. | $20.4M / Series C / Jun 16, 2021 | |
Teemyco
|
Teemyco is an internet company that features an online-based platform that connects employees online and enables them to conduct meeting online. The company specializes in providing virtual rooms designed for teams to customize. It was founded in 2019 and is headquartered in Stockholm, Sweden. | $3.3M / Seed / Jun 04, 2021 | |
Zelros
|
Zelros is an end-to-end AI business platform that integrate standard scenarios for sales & claims. Zelros is a technology helping insurers to better serve their clients with the support of Artificial Intelligence and Machine Learning. Current functionalities of their platform are augmented sales and predictive claim management. | $11M / Series A / Feb 24, 2021 | |
|
Superface
|
The future of APIs is true machine-to-machine communication. Autonomous APIs, decoupled components and self-driving clients are the foundation for voice interfaces and artificial intelligence. Superface uses super interface components that enable plug-and-play usage of data and services provided by companies using their API. | $1.5M / Pre-Seed / Apr 01, 2020 | |
| See all 13 investments → | |||
Co-Investors
About Zelros
Zelros is an end-to-end AI business platform that integrate standard scenarios for sales & claims. Zelros is a technology helping insurers to better serve their clients with the support of Artificial Intelligence and Machine Learning. Current functionalities of their platform are augmented sales and predictive claim management.
Zelros Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Christophe Bourguignat
Co-Founder, CEO
|
|||
Damien Philippon
COO, Co-Founder
|
|||
Fabien Vauchelles
CTO, Co-Founder
|
|||
|
Thomas Wilke
Investor
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Thomas Wilke invest in?
Thomas Wilke invests primarily in Software, Artificial Intelligence and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 13 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Thomas Wilke's check size?
Thomas Wilke typically joins rounds of $2.2M–$5.7M at Seed and $1.5M–$3.1M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Thomas Wilke participates in.
When did Thomas Wilke last invest?
The most recent investment recorded for Thomas Wilke closed in Apr 2026. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
